Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
estimated completion
Principal Investigator
by Miriam Kuppermann, PhD, MPH
Headshot of Miriam Kuppermann
Miriam Kuppermann

Description

Summary

The Periviable GOALS (Getting Optimal Alignment around Life Support) decision support tool (DST) is meant to facilitate informed shared decision-making regarding neonatal resuscitation for families facing the threat of a periviable delivery (deliveries occurring between 22 0/7 - 25 6/7 weeks gestational age). It is designed for parents to review independent of their clinician, and is intended to supplement, not replace, clinician counseling. The focus of the DST is the provision of patient-centered outcomes information and assistance with values clarification regarding neonatal outcomes. This is a multisite, randomized controlled trial to test the effect of the Periviable GOALS DST on shared decision making and decision satisfaction. The investigators hypothesize that participants who utilize the GOALS DST will have improved shared decision making and higher decision satisfaction.

Official Title

Promoting Shared Decision Making in Periviable Care: A Randomized Controlled Trial of the Periviable GOALS Decision Support Tool

Details

The investigators will evaluate the Periviable GOALS DST in a randomized controlled trial among 144 pregnant patients between 22 0/7 and 25 6/7 weeks gestation who are hospitalized for a pregnancy complication that threatens periviable delivery. Pregnant patients agreeing to participate will be asked to identify whom they will primarily rely on for assistance in making decisions regarding their delivery plan (e.g., father of the baby, partner, a family member, or any other important individual in the patient's life), referred to as the 'important other' (IO). In terms of IO recruitment goals, the investigators anticipate recruiting 72 IOs. This goal is based on our previous work with a similar population of pregnant patients, in which about half identified an 'important other' to be included in the study. Recruitment will be conducted at Indiana University (IU) and the University of California at San Francisco (UCSF). This study consists of 3-4 points of data collection, depending on group assignment. Participants will be randomized into a treatment group or control group at the start of the study. All participants will complete the T0 interview, which consists of a set of baseline questionnaires and survey instruments that will be administered in-person, prior to delivery and after they have been counseled on their neonatal treatment options. Immediately following T0, participants who are assigned to the control group will proceed with usual care. Participants who are randomized to the intervention will review the Periviable GOALS DST, which contains outcomes information, values clarification and embedded short documentary style videos. The content focuses largely on helping patients better understand the choice they have between comfort care and life-sustaining efforts in the context of periviable delivery. After viewing the DST, participants will repeat instruments from T0 and provide feedback regarding the tool's acceptability (T1). Another member of the research team will contact all participants to complete follow-up interviews to assess decision quality, neonatal treatment preference and outcome, and mental health. These interviews will be conducted on postpartum day 1 or 2 (T2), at three months postpartum (T3), and at six months postpartum (T4).

Keywords

Pregnancy Preterm, Premature Birth, Pregnancy Complications, Obstetric Labor, Premature, Obstetric Labor Complications, Decision making, Periviable delivery, Preterm birth, Risk Communication, Neonatal Resuscitation, Periviable GOALS DST

Eligibility

You can join if…

Open to people ages 18 years and up

for Pregnant Persons:

  • Adults (18 years or older)
  • Pregnant between 22 0/7 to 24 6/7 weeks gestation
  • Presenting to Labor & Delivery at an approved study site with a pregnancy complication that poses the potential threat of or need for periviable delivery (e.g., rupture of membranes, preterm labor, shortened cervix, pre-eclampsia, and growth restriction).
  • Must have been counseled on their neonatal treatment options (e.g. resuscitation, comfort care) by their healthcare team prior to being approached by the study team.

Inclusion Criteria for Important Others:

  • Adults (18 years or older)
  • 1 per pregnant person
  • Is identified by the pregnant person as someone who will be involved in making decisions for the baby
  • Must be present at the time of randomization to participate

You CAN'T join if...

  • Under 18 years of age
  • Incarcerated
  • Medically unstable (i.e. in active labor and dilated 6cm or more)
  • Emotionally unstable
  • Have not been counseled by their healthcare team regarding neonatal treatment options
  • Are not admitted to Labor & Delivery for reasons indicative of a threatened early delivery
  • If they are experiencing a known fatal fetal anomaly
  • Are not present at the time of randomization (only for important others)

Locations

  • University of California, San Francisco accepting new patients
    San Francisco California 94143 United States
  • Indiana University accepting new patients
    Indianapolis Indiana 46202 United States

Lead Scientist at UCSF

  • Miriam Kuppermann, PhD, MPH
    Miriam Kuppermann is a Professor in the Departments of Obstetrics, Gynecology & Reproductive Sciences (primary) and Epidemiology & Biostatistics (secondary).

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Indiana University
ID
NCT05264779
Study Type
Interventional
Participants
Expecting 216 study participants
Last Updated